Welcome to our dedicated page for Ovintiv SEC filings (Ticker: OVV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ovintiv Inc.'s SEC filings document the formal disclosure record for its oil, NGL and natural gas exploration and production operations in the United States and Canada. Form 8-K reports cover operating and financial results, dividend declarations, completed asset dispositions, acquisition-related financial statements and pro forma information, credit agreement activity, note redemption matters and Regulation FD exhibits.
Proxy and annual-meeting filings describe director elections, board committee assignments, advisory votes on executive compensation, auditor ratification and other shareholder voting matters. The filings also identify the company's common stock registration, capital-structure disclosures, material agreements and risk-factor discussions related to its E&P portfolio and financing activities.
King Terri Gay reported acquisition or exercise transactions in this Form 4 filing.
Ovintiv Inc. director Terri Gay King received a grant of 402 Deferred Share Units on July 29, 2026. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs held until retirement from the Board. Following this award, King directly holds 812 DSUs.
Gentle Meg reported acquisition or exercise transactions in this Form 4 filing.
Ovintiv Inc. director Meg Gentle received a grant of 486 Deferred Share Units on 2026-07-29, increasing her direct DSU holdings to 12,385 units. Each DSU is the economic equivalent of one common share and accumulates dividend-equivalent DSUs that are held until retirement from the Board.
Ovintiv Inc., a North American oil and gas producer, reported second-quarter 2026 total revenues of US$3,013 million, up from US$2,318 million a year earlier. Net earnings were US$456 million versus US$307 million, and diluted EPS rose to US$1.62 from US$1.18, as operating income nearly doubled to US$994 million.
For the first six months of 2026, total revenues reached US$5,545 million, but Ovintiv recorded a net loss of US$174 million compared with net earnings of US$148 million in the prior-year period, driven by US$1,485 million of impairments and a US$337 million loss on divestitures. Cash from operating activities strengthened to US$2,688 million from US$1,886 million, while capital expenditures were broadly steady at US$1,179 million. Proceeds from divestitures totaled US$2,829 million. As of June 30, 2026, long-term debt decreased to US$3,695 million from US$4,392 million at year-end 2025, cash and cash equivalents increased to US$700 million from US$35 million, total assets were US$19,280 million, and shareholders equity rose to US$11,499 million.
Ovintiv Inc. reported strong second quarter 2026 results, with total revenues of US$3,013 million, net earnings of US$456 million and diluted earnings per share of US$1.62, up from US$307 million and US$1.18 a year earlier. Cash from operating activities was US$1.6 billion, Non-GAAP Cash Flow approximately US$1.3 billion, and Non-GAAP Free Cash Flow US$682 million after capital expenditures of US$574 million. Average production was 614.6 MBOE/d, essentially flat year over year, and results included a US$337 million pre-tax loss on the Anadarko asset divestiture, which generated about US$2.82 billion in cash proceeds.
Balance sheet metrics improved, with Net Debt at US$2.995 billion and Net Debt to Adjusted EBITDA at 0.6x, supported by total liquidity of approximately US$4.4 billion. Second quarter shareholder returns totaled US$429 million, or about 63% of Non-GAAP Free Cash Flow, through US$345 million of share repurchases (6.1 million shares) and US$84 million of dividends. The board declared a US$0.30 per share quarterly dividend payable September 29, 2026 to shareholders of record on September 15, 2026.
For 2026, Ovintiv issued third quarter guidance and raised full-year production guidance to 630–645 MBOE/d, including oil and condensate of 210–212 Mbbls/d, while keeping expected capital investment unchanged at US$2.25–US$2.35 billion, targeting approximately 4% oil production per-share growth.
IZZO RALPH reported acquisition or exercise transactions in this Form 4 filing.
Ovintiv Inc. director Ralph Izzo received a grant of 41 Deferred Share Units (DSUs) as dividend-equivalent compensation. Each DSU is the economic equivalent of one share of Ovintiv common stock and accrues dividend-equivalent DSUs. These units were issued in lieu of cash dividends for the second quarter of 2026 and are held until Mr. Izzo retires from the Board. Following this award, he holds a total of 7,340 DSUs, each linked to an equivalent number of underlying common shares.
Chhina Sippy reported acquisition or exercise transactions in this Form 4 filing.
Ovintiv Inc. director Sippy Chhina received 15 Deferred Share Units (DSUs) as a grant tied to second-quarter 2026 cash dividends. Each DSU is economically equivalent to one share of Ovintiv common stock and accumulates dividend equivalents. After this award, Chhina holds 2,784 DSUs, which are retained until retirement from the board and do not represent an open-market share purchase or sale.
Givens Gregory Dean reported acquisition or exercise transactions in this Form 4 filing.
Ovintiv Inc.’s EVP & COO Gregory Dean Givens reported a grant of 441 Restricted Share Units (RSUs) tied to common stock. These RSUs are dividend-equivalent units received in lieu of a cash dividend for the second quarter of 2026 under Ovintiv’s Omnibus Incentive Plan.
Each RSU is economically equivalent to one Ovintiv common share and includes dividend-equivalent rights, vesting according to the applicable grant agreement and plan rules, contingent on continued employment. Following this award, Givens directly holds 78,697 RSUs representing compensation-based equity rather than open‑market purchases.
Ovintiv Inc. executive Meghan Nicole Eilers received an award of 263 Restricted Share Units (RSUs), including dividend-equivalent RSUs, linked to Ovintiv common stock. These RSUs were granted at no cash cost as compensation and increase her direct holdings to 46,955 shares on an as-converted basis.
The RSUs vest and become exercisable over time under Ovintiv’s Omnibus Incentive Plan and the related grant agreement, and remain subject to her continued employment with the company through the relevant vesting dates.
Ovintiv Inc. executive Rachel Maureen Moore, EVP of Corporate Services, received a grant of 208 Restricted Share Units, credited as dividend equivalent RSUs for the second quarter of 2026. Each RSU is economically equivalent to one share of Ovintiv common stock and accrues further dividend equivalents.
The RSUs vest and become exercisable under Ovintiv’s Omnibus Incentive Plan and the related grant terms, contingent on Moore’s continued employment through the applicable exercise date. Following this award, she holds 37,696 RSUs representing compensation-based equity exposure to Ovintiv stock.
McCracken Brendan Michael reported acquisition or exercise transactions in this Form 4 filing.
Ovintiv Inc.’s President & CEO Brendan Michael McCracken received a grant of 1,271 Restricted Share Units (RSUs) tied to common stock. These RSUs were issued as dividend equivalent units for the second quarter of 2026 rather than in cash.
Each RSU is economically equal to one Ovintiv common share and will vest and become exercisable under the company’s Omnibus Incentive Plan and the related grant agreement, subject to his continued employment. After this award, his reported directly held RSU-type units increased to 226,748.